News

Cleaning Validation Technical Guide - What Does China Expect in Terms of Cleaning Validation?

There are various guidelines on the topic of cleaning validation. A new addition is a technical guide from the Chinese “National Food and Drug Administration Food and Drug Inspection Center.” What does it cover?

More
ICH Q9 Training Package updated

Following the revision of the ICH Q9 guideline 'Quality Risk Management 2023', the accompanying training material was also published. This has now been updated with regard to the two annexes. Annex I describes quality risk methods and tools, and Annex II describes possible applications of quality risk management (QRM).

More
Risk Assessment as the Basis for Process Validation

In a recent Warning Letter, the FDA criticised the fact that not all parameters of a process were included in a process validation. What are the follow-up measures?

More
What does the FDA expect regarding Facility Maintenance?

In a previous news, you could already read about deficiencies in equipment maintenance. However, the FDA also criticised the manufacturer for deficiencies in facility maintenance. What does the FDA expect with regard to 21 CFR 211.58?

More
Revision of EU-GMP Annex 15: Increased Focus on Deviation Management

Annex 15 is about to become far more relevant for API manufacturers. Stronger requirements for deviation investigations and process understanding will raise the bar for quality oversight across the supply chain.

More
Rationale for Limit Selection in Process Validation

In a recent warning letter, the US FDA criticised deficiencies in the process validation of a tablet manufacturing process. In particular, the scientific justification for the selected process parameter limits was questioned.

More
The GMP Relevance of Equipment Maintenance from FDA's Perspective

In our News item "Dedicated Equipment Should also be Included in Cleaning Validation" dated 18.02.2026, we reported on deficiencies in cleaning validation that were criticised by the US FDA. However, this section of the FDA regulations addresses not only cleaning, but also equipment maintenance - an area in which the FDA identified significant deficiencies during its inspection. So, what specific deficiencies were highlighted by the FDA?

More
Dedicated Equipment Should also be Included in Cleaning Validation

In a recent Warning Letter, the U.S. FDA criticised inadequate cleaning of non-dedicated equipment. However, cleaning of dedicated equipment was also criticised. What did the FDA find?

More
What does the Concept Paper on Annex 15 Revision say? A detailed Analysis

In the previous newsletter, you could read about a concept paper from the EMA describing the planned changes to Annex 15 (Qualification and Validation) of the EU GMP Guidelines. Find out more in detail what the concept paper on the Annex 15 revision contains.

More
Process Validation: From Regulatory Burden to Stratgic Advantage

Jesper Wagner from NIRAS is a member of the ECA Validation Group. He has published an article in the online journal “Pharmaceutical Online” on the topic of “Process validation rethought: From mandatory requirement to strategic competitive advantage.” It is among the top 10 most-read articles of 2025 on Pharmaceutical Online. Read a summary.

More
x
Search